Peptide profile · Sexual Health
PT-141 (Bremelanotide)
The first FDA-approved peptide that works through your brain to reignite sexual desire—think of it as flipping the 'on' switch for arousal rather than just boosting blood flow like traditional ED meds.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team
Typical dose
1.75 mg
Half-life
2.7 hours
Bioavailability
~100% (subcutaneous injection)
Molecular weight
1025.2 g/mol
Evidence level
Strong human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C50H68N14O10
Primary benefits
Directly activates brain pathways controlling sexual motivation, with FDA approval based on significant improvements in desire scores
Works within 45-60 minutes and lasts several hours, providing flexibility without daily dosing commitment
One of the most thoroughly studied sexual health peptides, with Phase 3 trials, FDA approval, and long-term safety data
Palatin Technologies, Inc.
Amino acid sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH02 · Dosing
How much do I take?
1.75 mg · as needed, ~45 min before sexual activity; max once per 24 h and 8 doses per 28 days
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Best time to take
Take PT-141 at least 45 minutes before anticipated sexual activity. Effects typically begin within 45-60 minutes and can last several hours. Some people find it works better with 60-90 minutes lead time.
With food?
Taking PT-141 on an empty stomach may increase nausea. A light meal or snack beforehand can help reduce stomach upset without significantly affecting absorption.
If stacking
PT-141 is typically used as a standalone treatment. Its unique mechanism of action through melanocortin receptors means it doesn't directly interact with most other peptides, but consult your healthcare provider before combining with other treatments.
＋ Increase if
- +You tolerate the starting dose with minimal nausea
- +Effects feel insufficient after multiple tries at current dose
- +Your healthcare provider recommends adjustment based on your response
－ Decrease if
- −Nausea is severe or interferes with the experience
- −You experience significant blood pressure increases
- −Flushing or headaches are uncomfortable
- −Side effects outweigh the benefits
✓ Signs of right dose
- ✓Noticeable increase in sexual desire within 1-2 hours
- ✓Manageable or no nausea
- ✓Enhanced arousal response during intimacy
- ✓No significant blood pressure changes
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for restoring sexual desire & treating hypoactive sexual desire disorder (hsdd)
Best for
Women with Low Sexual Desire (HSDD)
PT-141 is FDA-approved specifically for premenopausal women with acquired, generalized hypoactive sexual desire disorder—when you used to have normal desire but it's faded, and it's causing real distress in your life. It's the only approved treatment that works through brain pathways rather than hormones.
Men Who Don't Respond to Viagra-Type Medications
While not FDA-approved for men, clinical research shows PT-141 may help men with erectile dysfunction who don't respond to PDE5 inhibitors like Viagra or Cialis. Because it works through the brain rather than blood vessels, it offers a completely different approach.
Those Wanting On-Demand Treatment
Unlike daily medications like flibanserin (Addyi), PT-141 is used only when you want it—take it 45 minutes before intimacy. This gives you control over timing without committing to daily pills.
People Seeking to Address the 'Wanting' Part of Intimacy
Many sexual health treatments focus on the physical mechanics (blood flow, lubrication). PT-141 is unique because it targets desire itself—the psychological 'wanting' that initiates intimacy. It works on your brain's arousal circuits.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare PT-141 (Bremelanotide) with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
Subcutaneous injection
Reconstitution — what you need
Example
For a 10mg vial: add 2mL of BAC water to get 5mg/mL concentration. For the standard 1.75mg dose, you'd draw 0.35mL (35 units on an insulin syringe). For 2mg, draw 0.4mL (40 units).
At 5mg/mL concentration: 1mg = 0.2mL (20 units); 1.75mg = 0.35mL (35 units); 2mg = 0.4mL (40 units). The FDA-approved Vyleesi autoinjector comes pre-dosed at 1.75mg and doesn't require reconstitution.
Route
Subcutaneous injection (just under the skin)—this is how the FDA-approved Vyleesi autoinjector delivers the dose
Best sites
Technique
- 01Wash your hands thoroughly with soap and water
- 02Clean the injection site with an alcohol swab and let it dry completely
- 03If using a syringe: pinch about an inch of skin to create a fold
- 04Insert the needle at a 45-90 degree angle (45 if lean, 90 if more tissue)
- 05Inject slowly and steadily over a few seconds
- 06Wait 5 seconds before withdrawing the needle
- 07Apply light pressure with a clean cotton ball if needed—don't rub
Storage · before reconstitution
Keep your PT-141 powder in the refrigerator (36-46°F / 2-8°C) for short-term storage or in the freezer (-4°F / -20°C) for long-term storage. Store in the original sealed vial away from light. Properly stored powder remains stable for 2+ years when frozen.
Storage · after reconstitution
Once mixed with bacteriostatic water, refrigerate at 36-46°F (2-8°C). Never freeze the reconstituted solution—freezing destroys the peptide. Keep away from light and use within 30 days. The FDA-approved Vyleesi autoinjector should also be refrigerated.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
4 common side effects · 2 serious
PT-141 has undergone rigorous FDA review and was approved in 2019 based on two large Phase 3 clinical trials involving over 1,200 women. The most common side effect is nausea (affecting about 40% of users), which typically decreases with repeated use. The drug causes transient increases in blood pressure (average 2-3 mmHg) and slight decreases in heart rate, which is why it's contraindicated in uncontrolled hypertension. Long-term safety data from the 52-week extension study showed no new safety concerns.
PT-141 (as Vyleesi) has strong safety data from FDA-required Phase 3 trials and ongoing post-marketing surveillance. It's one of the most thoroughly studied peptides for sexual health. The clinical trials were conducted by Palatin Technologies and AMAG Pharmaceuticals with FDA oversight.
Common side effects · experienced by some users
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- ×Severe nausea that makes the experience unpleasant or affects your health
- ×Significant blood pressure increases, especially if you feel chest discomfort or severe headache
- ×Noticeable skin darkening that concerns you (may be irreversible)
- ×Any signs of allergic reaction—hives, swelling, difficulty breathing
- ×The medication isn't providing the desired effect after multiple attempts
- ×You become pregnant or are trying to conceive
PT-141 (Vyleesi) is an FDA-approved medication, but it should be used under healthcare provider supervision. This information is educational—always consult your doctor about starting, stopping, or adjusting any medication. Report any unexpected side effects to your healthcare provider.
With other peptides
- !Melanotan II — Both act on melanocortin receptors. Combining them increases risk of side effects including nausea, blood pressure changes, and hyperpigmentation. Avoid using together.
- ✓Oxytocin — May complement PT-141 by enhancing emotional bonding aspects of intimacy. Generally considered safe to combine, but research is limited.
- ✓BPC-157 — No known direct interactions. BPC-157 works on different pathways (healing and gut health). Can likely be used in the same overall protocol.
With medications
- !Blood pressure medications — PT-141 affects blood pressure. Combining with antihypertensives may have unpredictable effects. Use only under medical supervision with monitoring.
- !Naltrexone blocks opioid receptors and may reduce PT-141's effectiveness through overlapping neural pathways. Effectiveness may be diminished.
- !PDE5 inhibitors (Viagra, Cialis) — Both affect cardiovascular parameters. While sometimes combined in research for ED, this should only be done under medical supervision due to additive effects.
- !MAO inhibitors — PT-141 affects dopamine and norepinephrine release. MAOIs can dangerously amplify these effects. Avoid combining.
With supplements
- ✓Ginger — Can help manage PT-141's nausea side effect. Safe and potentially helpful to take before your dose.
- ✓Caffeine — Both can affect blood pressure and heart rate. Moderate caffeine is probably fine, but avoid large amounts close to your PT-141 dose.
- ✓Alcohol — Can worsen flushing and nausea, and may affect sexual response. Best to minimize alcohol when using PT-141.
- ✓L-arginine — Both affect blood flow mechanisms. No known dangerous interactions, but effects may add up. Monitor how you feel.
06 · Effectiveness
How do I know it's working?
Strong human trials · first signs first dose (day 1)
Evidence level
Strong human trials
(Phase 3 or FDA approved)
How it works
Your brain has special receptors called melanocortin receptors that help control many things, including sexual desire. PT-141 activates these receptors, particularly one called MC4R, which is found in the part of your brain that controls motivation and reward. When PT-141 turns on these receptors, it triggers the release of dopamine—the 'feel good' chemical that makes you want things. Unlike Viagra, which just increases blood flow, PT-141 actually works on the 'wanting' part of your brain. It's like turning up the volume on your desire circuit rather than just making the plumbing work better.
Bremelanotide (PT-141) is a cyclic heptapeptide lactam analog of alpha-melanocyte-stimulating hormone (α-MSH), with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. It functions as a non-selective melanocortin receptor (MCR) agonist with high affinity for MC3R and MC4R subtypes. The MC4R, predominantly expressed in the medial preoptic area (mPOA) of the hypothalamus, is the receptor most relevant to sexual function at therapeutic doses. Activation of presynaptic MC4Rs on neurons in the mPOA leads to increased release of dopamine into the mesolimbic reward pathway, enhancing sexual motivation and desire. Unlike PDE5 inhibitors that act peripherally on vascular smooth muscle, bremelanotide's central mechanism addresses the psychological/motivational aspects of sexual response. The drug also has minor effects on MC1R (skin pigmentation) and causes transient cardiovascular effects (increased BP, decreased HR) through MC4R-mediated sympathetic activation. Elimination half-life is approximately 2.7 hours, with peak plasma concentrations reached about 1 hour post-injection.
What to expect
First dose (Day 1)
What you might notice
- •Nausea within 30-60 minutes (most common side effect)
- •Facial flushing or feeling warm
- •Sexual desire effects beginning around 45-60 minutes
- •Effects lasting several hours
What's normal
- •Mild to moderate nausea that resolves on its own
- •Warmth in face and chest area
- •Gradual increase in feelings of desire or arousal
- •Subtle changes—this isn't an instant 'switch flip' for everyone
What's next
- →Note your response to gauge future dosing
- →If nausea was severe, consider eating beforehand next time
- →Wait at least 24 hours before considering another dose
- →Many people find effects improve with experience
First few uses
What you might notice
- •Nausea often decreases with repeated use
- •You learn your optimal timing (some need 60-90 minutes)
- •Effects may feel more predictable
- •Better understanding of what to expect
What's normal
- •Some variation in effect from dose to dose
- •Learning what food/timing works best for you
- •Mild side effects that are manageable
- •Clearer sense of whether PT-141 is working for you
What's next
- →Establish your personal protocol based on experience
- →Discuss with your healthcare provider if effects are inadequate
- →Stay within 8 doses per month maximum
- →Monitor for any skin changes with ongoing use
Ongoing use (months)
What you might notice
- •Consistent effects if PT-141 works for you
- •Tolerance does not appear to develop significantly
- •Watch for potential skin hyperpigmentation
- •Continued manageable side effects
What's normal
- •Stable response pattern over time
- •Continued mild nausea/flushing with each dose
- •No need to increase dose for same effect
- •Possible slight skin darkening in some areas
What's next
- →Continue as prescribed by your healthcare provider
- →Regular check-ins to assess ongoing benefit vs. side effects
- →Report any concerning skin changes
- →Reevaluate periodically whether treatment is still needed
Signs it's working · Sexual Desire Indicators
- ✓Increased spontaneous thoughts about intimacy
- ✓Greater interest in initiating sexual activity
- ✓Feeling more 'in the mood' than baseline
- ✓Reduced distress about low desire
- ✓More anticipation or excitement about intimacy
Signs it's working · Physical Response Indicators
- ✓Enhanced physical arousal response
- ✓Improved natural lubrication (women)
- ✓Better erectile response (men, off-label use)
- ✓More satisfying intimate experiences overall
- ✓Body feels more 'responsive' to stimulation
Not seeing results? Common reasons
- •Not waiting long enough—PT-141 needs at least 45-60 minutes to take effect, some people need 90 minutes
- •Nausea overwhelming the experience—try eating a light meal beforehand or starting with a lower dose
- •Relationship or psychological factors—PT-141 enhances desire but can't fix underlying relationship issues
- •Expectations too high—effects are often subtle and enhance rather than create desire from nothing
- •Inconsistent timing—finding your personal 'sweet spot' for timing takes experimentation
- •Medication interactions—naltrexone or other drugs may be blocking the effect
Key research
07 · Clinical trials
Tested in people
10 registered studies, none currently enrolling.
10
registered studies
0
recruiting now
5
phase 3 or 4
4
with published results
By phase
A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.
What kind of research
About 2,644 people took part in the studies that actually administered PT-141 (Bremelanotide). Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.
Most recent
Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
Cosette Pharmaceuticals, Inc.
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Palatin Technologies, Inc
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Palatin Technologies, Inc
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when PT-141 (Bremelanotide) is named as an intervention; studies that only mention it in passing are not.
08 · Questions
Frequently asked
How is PT-141 different from Viagra or Cialis?+
Viagra and Cialis work by increasing blood flow to the genitals—they help with the physical mechanics of arousal but don't affect desire. PT-141 works in your brain, activating receptors that control motivation and wanting. It's the difference between the plumbing working and actually wanting to be intimate in the first place. That's why PT-141 can help people whose bodies work fine but who've lost the 'spark' of desire.
Will PT-141 make me feel aroused all the time?+
No—PT-141 enhances your natural desire response rather than creating constant arousal. You'll likely feel more receptive to intimacy and more easily aroused when appropriate situations arise, but you won't be walking around in a constant state of arousal. Think of it as lowering the threshold for desire, not forcing it.
Why does PT-141 cause nausea?+
Melanocortin receptors aren't just in your brain's desire centers—they're also involved in other functions, including some related to the gut and nausea response. The good news is that nausea typically decreases with repeated use, and eating a light snack before your dose helps many people. Some users find starting at a lower dose (1mg) and working up reduces nausea.
Can men use PT-141?+
While PT-141 is only FDA-approved for women with HSDD, research has shown it can help men with erectile dysfunction—particularly those who don't respond to Viagra-type medications. Clinical trials in men have shown positive results, and Palatin Technologies is actively developing it for male ED. Currently, men would be using it off-label.
How often can I use PT-141?+
The FDA recommends no more than one dose per 24 hours and no more than 8 doses per month. This isn't about building tolerance (which doesn't seem to happen), but about limiting cumulative side effects like skin hyperpigmentation and ensuring cardiovascular safety.
Will PT-141 darken my skin permanently?+
PT-141 can cause focal hyperpigmentation (darkening) of the gums, face, or breasts with repeated use, especially in people with darker skin tones. This is because melanocortin receptors also control skin pigmentation. In some cases, this darkening may not fully reverse. Staying within the recommended 8 doses per month limit helps minimize this risk.
Can I take PT-141 with alcohol?+
While there's no dangerous interaction, alcohol can worsen PT-141's flushing side effect and may actually reduce sexual response in general. For the best experience, minimize alcohol when using PT-141. A glass of wine is probably fine, but avoid heavy drinking.
Is the Vyleesi autoinjector the only way to take PT-141?+
The FDA-approved form (Vyleesi) comes as a pre-filled autoinjector that's simple to use. However, compounding pharmacies also provide PT-141 as lyophilized powder that you reconstitute and inject yourself with insulin syringes. The active ingredient is the same, but only the Vyleesi autoinjector has FDA approval.